No difference was observed in the frequency of CD4+, CD8+, CD11b+, and CD11c+ cells in the LN cells of BD mice treated intraperitoneally or orally with butyrate (Supplementary Figure S1). This evidence concerns the gene ITGAX and Behcet disease.